Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
HTR2A and ANKS1B 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled ankyrin repeat and sterile alpha motif domain containing 1B
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • Signaling by GPCR
  • GPCR downstream signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Class A/1 (Rhodopsin-like receptors)
  • Amine ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Serotonin receptors
  • Ziprasidone
  • Methysergide
  • Cabergoline
  • Ropinirole
  • Amitriptyline
  • Olanzapine
  • Clozapine
  • Mirtazapine
  • Loxapine
  • Remoxipride
  • Pramipexole
  • Promazine
  • Cyproheptadine
  • Imipramine
  • Chlorpromazine
  • Haloperidol
  • Nortriptyline
  • Lisuride
  • Cisapride
  • Trazodone
  • Thioridazine
  • Ergotamine
  • Apomorphine
  • Paroxetine
  • Trimipramine
  • Risperidone
  • Epinastine
  • Propiomazine
  • Minaprine
  • Donepezil
  • Flupenthixol
  • Cyclobenzaprine
  • Mesoridazine
  • Promethazine
  • Tegaserod
  • Doxepin
  • Nefazodone
  • Desipramine
  • Pergolide
  • Bromocriptine
  • Quetiapine
  • Aripiprazole
  • Chlorprothixene
  • Clomipramine
  • Paliperidone
  • Dihydroergotoxine
  • Yohimbine
  • Methotrimeprazine
  • MMDA
  • 3,4-Methylenedioxymethamphetamine
  • Dimethyltryptamine
  • Acepromazine
  • Molindone
  • Pipotiazine
  • Thioproperazine
  • Thiothixene
  • Zuclopenthixol
  • Aniracetam
  • Fluspirilene
  • Iloperidone
  • Sertindole
  • Mianserin
  • Asenapine
  • Amisulpride
  • Cinitapride
  • Lurasidone
HTR2A and NTRK3 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled neurotrophic tyrosine kinase, receptor, type 3
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • Signaling by GPCR
  • GPCR downstream signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Class A/1 (Rhodopsin-like receptors)
  • Amine ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Serotonin receptors
  • Ziprasidone
  • Methysergide
  • Cabergoline
  • Ropinirole
  • Amitriptyline
  • Olanzapine
  • Clozapine
  • Mirtazapine
  • Loxapine
  • Remoxipride
  • Pramipexole
  • Promazine
  • Cyproheptadine
  • Imipramine
  • Chlorpromazine
  • Haloperidol
  • Nortriptyline
  • Lisuride
  • Cisapride
  • Trazodone
  • Thioridazine
  • Ergotamine
  • Apomorphine
  • Paroxetine
  • Trimipramine
  • Risperidone
  • Epinastine
  • Propiomazine
  • Minaprine
  • Donepezil
  • Flupenthixol
  • Cyclobenzaprine
  • Mesoridazine
  • Promethazine
  • Tegaserod
  • Doxepin
  • Nefazodone
  • Desipramine
  • Pergolide
  • Bromocriptine
  • Quetiapine
  • Aripiprazole
  • Chlorprothixene
  • Clomipramine
  • Paliperidone
  • Dihydroergotoxine
  • Yohimbine
  • Methotrimeprazine
  • MMDA
  • 3,4-Methylenedioxymethamphetamine
  • Dimethyltryptamine
  • Acepromazine
  • Molindone
  • Pipotiazine
  • Thioproperazine
  • Thiothixene
  • Zuclopenthixol
  • Aniracetam
  • Fluspirilene
  • Iloperidone
  • Sertindole
  • Mianserin
  • Asenapine
  • Amisulpride
  • Cinitapride
  • Lurasidone
DCP2 and DCP1B decapping mRNA 2 decapping mRNA 1B
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • KSRP destabilizes mRNA
  • ATF4 activates genes
  • mRNA decay by 5' to 3' exoribonuclease
  • Tristetraprolin (TTP) destabilizes mRNA
  • PERK regulates gene expression
  • Unfolded Protein Response (UPR)
  • Deadenylation-dependent mRNA decay
  • Butyrate Response Factor 1 (BRF1) destabilizes mRNA
  • mRNA decay by 5' to 3' exoribonuclease
  • Deadenylation-dependent mRNA decay
IRF8 and NFKB1 interferon regulatory factor 8 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Interferon gamma signaling
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon alpha/beta signaling
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Thalidomide
  • Pranlukast
  • Triflusal
ID1 and TCF4 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein transcription factor 4
  • Cellular Senescence
  • Oncogene Induced Senescence
  • CDO in myogenesis
  • Myogenesis
ID2 and TCF4 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein transcription factor 4
  • CDO in myogenesis
  • Myogenesis
ID3 and TCF4 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein transcription factor 4
  • CDO in myogenesis
  • Myogenesis
ID4 and TCF4 inhibitor of DNA binding 4, dominant negative helix-loop-helix protein transcription factor 4
  • CDO in myogenesis
  • Myogenesis
IFRD1 and HDAC4 interferon-related developmental regulator 1 histone deacetylase 4
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
IGF2 and BAG6 insulin-like growth factor 2 BCL2-associated athanogene 6
  • IRS-related events triggered by IGF1R
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Response to elevated platelet cytosolic Ca2+
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • SHC-related events triggered by IGF1R
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • IGF1R signaling cascade
IGFBP5 and BAG6 insulin-like growth factor binding protein 5 BCL2-associated athanogene 6
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
RBPJ and NOTCH4 recombination signal binding protein for immunoglobulin kappa J region notch 4
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • NOTCH2 intracellular domain regulates transcription
  • Notch-HLH transcription pathway
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH2
  • Regulation of beta-cell development
  • Generic Transcription Pathway
  • Pre-NOTCH Transcription and Translation
  • Signaling by NOTCH1
  • Pre-NOTCH Expression and Processing
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Notch-HLH transcription pathway
  • Signaling by NOTCH4
  • Generic Transcription Pathway
  • Pre-NOTCH Processing in Golgi
  • Pre-NOTCH Transcription and Translation
  • Signaling by NOTCH
  • Pre-NOTCH Processing in the Endoplasmic Reticulum
  • Pre-NOTCH Expression and Processing
IKBKB and NFKB1 inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • RIP-mediated NFkB activation via ZBP1
  • IRAK1 recruits IKK complex
  • Downstream signaling events of B Cell Receptor (BCR)
  • Toll Like Receptor TLR1:TLR2 Cascade
  • FCERI mediated NF-kB activation
  • Toll Like Receptor 5 (TLR5) Cascade
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • TCR signaling
  • Signaling by Interleukins
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Downstream TCR signaling
  • p75NTR recruits signalling complexes
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Innate Immune System
  • Signalling by NGF
  • IKK complex recruitment mediated by RIP1
  • Cytosolic sensors of pathogen-associated DNA
  • p75 NTR receptor-mediated signalling
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Activation of NF-kappaB in B cells
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Mesalazine
  • Sulfasalazine
  • Auranofin
  • Arsenic trioxide
  • Thalidomide
  • Pranlukast
  • Triflusal
IL1A and IL1R2 interleukin 1, alpha interleukin 1 receptor, type II
  • Signaling by Interleukins
  • Interleukin-1 processing
  • Cellular Senescence
  • Interleukin-1 signaling
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • Cytokine Signaling in Immune system
  • Interleukin-1 signaling
IL1B and IL1R2 interleukin 1, beta interleukin 1 receptor, type II
  • Signaling by Interleukins
  • Interleukin-1 processing
  • Interleukin-1 signaling
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • Cytokine Signaling in Immune system
  • Interleukin-1 signaling
  • Minocycline
  • Gallium nitrate
  • Canakinumab
  • Rilonacept
IL1RAP and IL1R2 interleukin 1 receptor accessory protein interleukin 1 receptor, type II
  • Signaling by Interleukins
  • Cytokine Signaling in Immune system
  • Interleukin-1 signaling
IL1RN and IL1R2 interleukin 1 receptor antagonist interleukin 1 receptor, type II
  • Signaling by Interleukins
  • Cytokine Signaling in Immune system
  • Interleukin-1 signaling
  • Signaling by Interleukins
  • Cytokine Signaling in Immune system
  • Interleukin-1 signaling
IL2RA and NFKB1 interleukin 2 receptor, alpha nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • GPCR downstream signaling
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Denileukin diftitox
  • Aldesleukin
  • Basiliximab
  • Daclizumab
  • Thalidomide
  • Pranlukast
  • Triflusal
IL3 and IL3RA interleukin 3 interleukin 3 receptor, alpha (low affinity)
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Amlexanox
  • Sargramostim
IL3RA and LNX1 interleukin 3 receptor, alpha (low affinity) ligand of numb-protein X 1, E3 ubiquitin protein ligase
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Sargramostim

Page 28 out of 82 pages